This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Henrik Johansson Castro, PhD
Senior Development Scientist at Novo Nordisk
Speaker

Profile

Henrik is a Senior Development Scientist in the Early-Stage Synthetic Peptide Team in Novo Nordisk CMC Chemical Development. He has a background in medicinal chemistry, obtaining BSc and MSc degrees from Lund University and his PhD degree from the University of Copenhagen respectively. After postdoctoral work with GSK and the Francis Crick Institute in London, Henrik joined Novo Nordisk in 2020 where he works with process development and innovation in the synthetic peptide field.

Agenda Sessions

  • Developing Tag-Assisted Peptide Synthesis for Manufacturing Scale

    16:00